Thus, upregulation of ESRP1/ESRP2 gene expression in aggressive tumours, by either gene amplification or in response to androgens could be different means to the same end, and drive the progression of aggressive prostate cancer in a similar way. Here, ESRP1 is linked to prostate cancer.